Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cameron Brennan

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Cell|May 30, 2020
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune CellsFlorian Klemm, Roeltje R Maas, Robert L Bowman, et al.
Cancer Research|November 9, 2006
A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastomaFenghua Liu, Peter J Park, Weil Lai, et al.
Plos One|June 4, 2010
Integrative genome comparison of primary and metastatic melanomasOmar Kabbarah, Cristina Nogueira, Bin Feng, et al.
Cancer Cell|January 13, 2026
Characterization of a pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionKenny Kwok Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
A pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionKenny Kwok Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade GliomaVirginia Aragon-Sanabria, Anusha Aditya, Li Zhang, et al.
Science Advances|February 11, 2021
Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancerNicole Oatman, Nupur Dasgupta, Priyanka Arora, et al.
Nature Genetics|November 29, 2017
Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistenceSevin Turcan, Vladimir Makarov, Julian Taranda, et al.
Cancer Cell|April 18, 2006
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patientsDaniel R Carrasco, Giovanni Tonon, Yongsheng Huang, et al.
Genes & Development|April 18, 2012
Emerging insights into the molecular and cellular basis of glioblastomaGavin P Dunn, Mikael L Rinne, Jill Wykosky, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Cell|May 30, 2020
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune CellsFlorian Klemm, Roeltje R Maas, Robert L Bowman, et al.
Cancer Research|November 9, 2006
A genome-wide screen reveals functional gene clusters in the cancer genome and identifies EphA2 as a mitogen in glioblastomaFenghua Liu, Peter J Park, Weil Lai, et al.
Plos One|June 4, 2010
Integrative genome comparison of primary and metastatic melanomasOmar Kabbarah, Cristina Nogueira, Bin Feng, et al.
Cancer Cell|January 13, 2026
Characterization of a pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionKenny Kwok Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, et al.
Biorxiv : the Preprint Server for Biology|March 3, 2025
A pathogenic subpopulation of human glioma associated macrophages linked to glioma progressionKenny Kwok Hei Yu, Zaki Abou-Mrad, Kristof Törkenczy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 2, 2022
Ultrasmall Nanoparticle Delivery of Doxorubicin Improves Therapeutic Index for High-Grade GliomaVirginia Aragon-Sanabria, Anusha Aditya, Li Zhang, et al.
Science Advances|February 11, 2021
Mechanisms of stearoyl CoA desaturase inhibitor sensitivity and acquired resistance in cancerNicole Oatman, Nupur Dasgupta, Priyanka Arora, et al.
Nature Genetics|November 29, 2017
Mutant-IDH1-dependent chromatin state reprogramming, reversibility, and persistenceSevin Turcan, Vladimir Makarov, Julian Taranda, et al.
Cancer Cell|April 18, 2006
High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patientsDaniel R Carrasco, Giovanni Tonon, Yongsheng Huang, et al.
Genes & Development|April 18, 2012
Emerging insights into the molecular and cellular basis of glioblastomaGavin P Dunn, Mikael L Rinne, Jill Wykosky, et al.
Pageof 9